Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xeris Pharmaceuticals Inc

5.11
-0.1600-3.04%
Post-market: 5.110.00000.00%17:52 EDT
Volume:1.52M
Turnover:7.81M
Market Cap:818.39M
PE:-16.98
High:5.28
Open:5.24
Low:5.10
Close:5.27
Loading ...
Jul 28, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 19, 2021

Major Issues Report

8-K - Current report
Jul 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 08, 2021

Major Issues Report

8-K - Current report
May 25, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 24, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 24, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 24, 2021

Major Issues Report

8-K - Current report
May 24, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Major Issues Report

8-K - Current report
Mar 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals